AGENDA

Day 2: Symposium #1 – Central Park east 

Redefining Cancer Care: Research, Innovation, and the Human Experience

Get Pass
Sponsor

9:30 AM

Introduction

Cole Manship, Product Strategy and Innovation at Memorial Sloan Kettering Cancer Center

9:35 AM

CancerX and USCDI+ Cancer

Stephen Konya, Chief, Innovation and Strategic Partnerships, Assistant Secretary for Technology Policy (ASTP), U.S. Department of Health and Human Services (HHS)

10:00 AM

Transforming Pain into Power: The Caregiver’s Role in Operationalizing Cancer Innovation

Erica Olenski, Vice President, FINN Partners

10:35 AM

Networking BREAK

11:00 AM

Bridging the Divide: Tackling Disparities in Cancer Trials and Access

Dr. Larry Norton, Senior VP, Office of the Hospital President, Memorial Sloan Kettering Cancer Center

11:30 AM

Immunogenik’s Vision for Next-Generation Immunotherapies: Precision, Modulation, and Impact

Dr. Jianping Huang, Founder & CEO, Immunogenik

12:00 PM

The Evolution of Oncology Navigation and How Technology Will Help

Steve Whitty, Co-Founder & CEO, BluePrint Nav

Tricia Strusowski, MS, RN Navigation Product Leader, Turnkey Oncology

12:30 PM

LUNCH

1:30 PM

Backing the Breakthroughs: Where Capital Meets Cancer Innovation

Rachel Ravens, CEO, 42Genetics, Partner at 46Health

Natalie Shtrizent, CEO, Frezent

Sian Farrell, CEO, StimOxyGen

Giuseppe Del Priore, CMO, BriaCell

2:00 PM

Accelerating Impact: Collaborations Fueling the Next Generation of Cancer Treatment

Rachel Ravens, CEO, 42Genetics, Partner at 46Health

Dr. Faisal Mahmood, Associate Prof of Pathology at Harvard Medical School and the Division of Computational Pathology at the Birmingham and Women’s Hospital

2:30 PM

NETWORKING BREAK

3:00 PM

Practical Applications for AI in Healthcare Workshop

Meg Columbia Walsh, Managing Director, Oberon Securities

3:30 PM

Practical Applications for AI in Healthcare Workshop

Meg Columbia Walsh, Managing Director, Oberon Securities